Please login to the form below

Not currently logged in
Email:
Password:

degarelix

This page shows the latest degarelix news and features for those working in and with pharma, biotech and healthcare.

NICE finally set to back wider use of Ferring's Firmagon

NICE finally set to back wider use of Ferring's Firmagon

Ferring's Firmagon (degarelix) has been recommended for use by the NHS in England by the country's cost-effectiveness watchdog NICE. ... In a statement NICE said its appraisal committee “ acknowledged the particular benefit of degarelix for people with

Latest news

  • NICE gives partial backing to Ferring's prostate cancer drug NICE gives partial backing to Ferring's prostate cancer drug

    Final draft guidance published by NICE recommends that Firmagon (degarelix depot) should be offered to patients with advanced hormone-dependent prostate cancer that has metastasised to the spine and could compress ... Degarelix is a

  • Close but no cigar

    Acanya (Arcutis, Dow). Acne vulgaris. US, Europe. Degarelix. FIRMAGON (Ferring). Prostate cancer.

More from news
Approximately 2 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make...

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...

Infographics